[Event and Publication Report] The Dementia Innovation Readiness Index 2020 Launch Webinar (October 8, 2020)
date : 10/19/2020
Tags: Dementia
Health and Global Policy Institute (HGPI) Chairman Dr. Kiyoshi Kurokawa spoke at an online event commemorating the release of Dementia Innovation Readiness Index 2020. At the event, Dr. Kurokawa gave high praise to policies for dementia implemented by the national Government and Tokyo Municipal Government and spoke on the importance of further accelerating efforts to promote understanding and build awareness together with multi-stakeholders including the public and NPOs in the future. Dr. Kurokawa also noted that he has high expectations for digital technology, especially more accurate diagnostic technology, to contribute to solving issues in dementia in the future.
The Dementia Innovation Readiness Index is an annual report that is produced by the Global Coalition on Aging (GCOA) and Alzheimer’s Disease International (ADI) in partnership with Singapore’s Lien Foundation. This year’s Dementia Innovation Readiness Index 2020 assessed thirty cities worldwide using 26 indicators including the situation surrounding dementia treatment, measures for dementia prevention and risk reduction, and efforts to promote care and innovation. Tokyo was included as one of those thirty cities. The situation in each city and their efforts were then assigned scores ranging from zero to ten for each category.
Tokyo’s overall dementia readiness score was 7.3, placing it seventh among the thirty cities. Tokyo received a 6.1 for “Early detection and diagnosis,” putting it in sixteenth place for that category. This score was relatively low compared to Tokyo’s scores in other categories. Furthermore, the ability of General Practitioners (GPs, which are also referred to as family doctors in Japan) to diagnose and treat dementia scored highly, but the presence and awareness-building activities of specialists for the senior population and the public availability of reliable diagnosis rates were pointed out as weaknesses.
HGPI Manager Mr. Shunichiro Kurita was interviewed during the creation of the report. Mr. Kurita provided an overview of dementia policy in Japan with a focus on efforts in Tokyo.
For the full report, please visit the link below.
https://www.alz.co.uk/dementia-innovation-readiness-index
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-05-15
[Registration Open] (Webinar) The 2nd J-PEP Seminar – A New Framework for Providing Information on Clinical Trial Participant Recruitment – Legal Points to Consider from the Perspective of Meaningful Involvement (June 15, 2026)
-
2026-05-18
[Registration Closed] Kick-off Panel Discussion “From Africa and Japan, Drawing from Perspectives Around the World:A Platform for Cultivating a Philosophical Health Dialogue Together” (June 15, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)



